Hoover Financial Advisors’s Elevance Health ELV Stock Holding History

Hoover Financial Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$6K	Buy	+16	New	+$6.11K	﹤0.01%	524

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hoover Financial Advisors's ELV Position: Q2 2021 in Review

Hoover Financial Advisors opened a new position in Elevance Health (ELV) in Q2 2021: 16 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #524 among its holdings.

1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

Hoover Financial Advisors held 16 shares of Elevance Health worth $6K as of Q2 2021.
Elevance Health was a new Hoover Financial Advisors position in Q2 2021.
Elevance Health made up ﹤0.01% of Hoover Financial Advisors's portfolio in Q2 2021, its #524 holding.
1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.